Clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis
10.3760/cma.j.issn.1008-6706.2011.18.009
- VernacularTitle:柳氮磺吡啶结肠溶胶囊联合云南白药治疗溃疡性结肠炎
- Author:
Kunting DU
;
Qinli GE
;
Weijie YANG
;
Shunmei WAN
- Publication Type:Journal Article
- Keywords:
Colitis,ulcerative;
Sulfasalazine;
Yunnanbaiyao
- From:
Chinese Journal of Primary Medicine and Pharmacy
2011;18(18):2465-2466
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis. MethodsSixty patients with ulcerative colitis were randomly divided into two groups,thirty cases in treatment group and thirty cases in control group. Patients in treatment group received sulfasalazine capsulae enterosolubilis with Ytmnanbaiyao orally,patients in control group were given sulfasalazine capsulae enterosolubilis orally only. ResultsThe total effective rate of treatment group was 90. 0％ ,clinical recovery rate was 73.3％ ;The total effective rate of control group was 66.7％ ,clinical recovery rate was 43.3％ ,the differences was statistically significant(P ＜0.05). ConclusionThe clinical effect of sulfasalazine capsulae enterosolubilis with Yunnanbaiyao for ulcerative colitis was good,and should be used furthedy.
